Page 27 - MI-1-1
P. 27

Microbes & Immunity                                      RANTES/CCL5 and ezrin peptide RepG3 for long COVID



               2023.   Available  from:  https://www.ons.gov.uk/  2007;3(3):164-170.
               peoplepopulationandcommunity/healthandsocialcare/     doi: 10.1038/ncpneph0418
               conditionsanddiseases/articles/coronaviruscovid19l
               atestinsights/vaccines#deaths-by-vaccination-status  [Last  21.  Sullivan NL, Eickhoff CS, Zhang X, Giddings OK, Lane TE,
               accessed on 2024 Jan 17].                          Hoft DF. Importance of the CCR5-CCL5 axis for mucosal
                                                                  Trypanosoma cruzi protection and B  cell activation.
            11.  Parry PI, Lefringhausen A, Turni C,  et al. “Spikeopathy”:   J Immunol. 2011;187(3):1358-1368.
               COVID-19 spike protein is pathogenic, from both virus and
               vaccine mRNA. Biomedicines. 2023;11(8):2287.       doi: 10.4049/jimmunol.1100033
               doi: 10.3390/biomedicines11082287               22.  Bhat  H,  Zaun  G,  Hamdan  TA,  et al.  Arenavirus  induced
                                                                  CCL5 expression causes NK cell-mediated melanoma
            12.  Trougakos IP, Terpos E, Alexopoulos H, et al. Adverse effects   regression. Front Immunol. 2020;11:1849.
               of COVID-19 mRNA vaccines: The spike hypothesis. Trends
               Mol Med. 2022;28(7):542-554.                       doi: 10.3389/fimmu.2020.01849
               doi: 10.1016/j.molmed.2022.04.007               23.  Crawford A, Angelosanto JM, Nadwodny KL, Blackburn SD,
                                                                  Wherry EJ. A role for the chemokine RANTES in regulating
            13.  Yonker LM, Swank Z, Bartsch YC, et al. Circulating spike   CD8 T cell responses during chronic viral infection. PLoS
               protein detected in post-COVID-19 mRNA vaccine     Pathog. 2011;7(7):e1002098.
               myocarditis. Circulation. 2023;147(7):867-876.
                                                                  doi: 10.1371/journal.ppat.1002098
               doi: 10.1161/CIRCULATIONAHA.122.061025
                                                               24.  Blanco R, Gómez de Cedrón M, Gámez-Reche L, et al. The
            14.  Brogna C, Cristoni S, Marino G,  et al. Detection of
               recombinant Spike protein in the blood of individuals   chemokine receptor CCR5 links memory CD4(+) T cell
                                                                  metabolism to T cell antigen receptor nanoclustering. Front
               vaccinated against SARS-CoV-2: Possible  molecular   Immunol. 2021;12:722320.
               mechanisms. Proteomics Clin Appl. 2023;17(6):e2300048.
                                                                  doi: 10.3389/fimmu.2021.722320
               doi: 10.1002/prca.202300048
                                                               25.  Culley FJ, Pennycook AM, Tregoning JS, et al. Role of CCL5
            15.  Aldén M, Olofsson Falla F, Yang D, et al. Intracellular reverse
               transcription of pfizer BioNTech COVID-19 mRNA vaccine   (RANTES) in viral lung disease. J Virol. 2006;80:8151-8157.
               BNT162b2 in vitro in human liver cell line. Curr Issues Mol      doi: 10.1128/JVI.00496-06
               Biol. 2022;44:1115-1126.                        26.  Glass  WG, Rosenberg  HF,  Murphy PM.  Chemokine
               doi: 10.3390/cimb44030073                          regulation of inflammation during acute viral infection.
                                                                  Curr Opin Allergy Clin Immunol. 2003;3:467-473.
            16.  Khan S, Shafiei M, Longoria C, Schoggins J, Savani S, Hasan
               Zaki H. SARS-CoV-2 spike protein induces inflammation      doi: 10.1097/00130832-200312000-00008
               via TLR2-dependent activation of the NF-κB pathway. Elife.   27.  Khalil BA, Elemam NM, Maghazachi AA. Chemokines and
               2021;10:e68563.                                    chemokine receptors during COVID-19 infection. Comput
               doi: 10.7554/eLife.68563                           Struct Biotechnol J. 2021;19:976-988.
            17.  Faist A, Schloer S,  Mecate-Zambrano A,  et al. Inhibition      doi: 10.1016/j.csbj.2021.01.034
               of p38 signaling curtails the SARS-CoV-2 induced   28.  Zhao Y, Qin L, Zhang P,  et al. Longitudinal COVID-19
               inflammatory response but retains the IFN-dependent   profiling associates IL-1RA and IL-10 with disease
               antiviral defense of the lung epithelial barrier. Antiviral Res.   severity and RANTES with mild disease.  JCI Insight.
               2023;209:105475.
                                                                  2020;5(13):e139834.
               doi: 10.1016/j.antiviral.2022.105475               doi: 10.1172/jci. insight.139834
            18.  Holms RD, Ataullakhanov RI. Ezrin peptide therapy   29.  Pérez-García F, Martin-Vicente M, Rojas-García RL, et al.
               from HIV to COVID: Inhibition of inflammation and   High SARS-CoV-2 Viral load and low CCL5 expression
               amplification of adaptive anti-viral immunity. Int J Mol Sci.   levels in the upper respiratory tract are associated with
               2021;22:11688.
                                                                  COVID-19 severity. J Infect Dis. 2022;225:977-982.
               doi: 10.3390/ijms222111688
                                                                  doi: 10.1093/infdis/jiab604
            19.  Zeng Z, Lan T, Wei Y, Wei X. CCL5/CCR5 axis in human   30.  Law AHY, Lee DCW, Cheung BKW, Yim HCH, Lau ASY.
               diseases and related treatments. Genes Dis. 2022;9:12-27.
                                                                  Role for nonstructural protein 1 of severe acute respiratory
               doi: 10.1016/j.gendis.2021.08.004                  syndrome coronavirus in chemokine dysregulation. J Virol.
                                                                  2007;81:416-422.
            20.  Krensky AM, Ahn YT. Mechanisms of disease: Regulation
               of RANTES (CCL5) in renal disease. Nat Clin Pract Nephrol.      doi: 10.1128/JVI.02336-05


            Volume 1 Issue 1 (2024)                         21                               doi: 10.36922/mi.2474
   22   23   24   25   26   27   28   29   30   31   32